ACHN
Achillion Pharmaceuticals, Inc.
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
137 hedge funds and large institutions have $394M invested in Achillion Pharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 41 increasing their positions, 40 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
137
Holders Change
+13
Holders Change %
+10.48%
% of All Funds
3.14%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
26
Increased
41
Reduced
40
Closed
13
Calls
$632K
Puts
$259K
Net Calls
+$373K
Net Calls Change
+$98K
Top Buyers
| 1 |
MCO
MAK Capital One
New York
|
+$7.16M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.61M |
| 3 |
NC
Nexthera Capital
New York
|
+$5.83M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$5.1M |
| 5 |
Millennium Management
New York
|
+$4.66M |
Top Sellers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$8.55M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$8.46M |
| 3 |
AC
Armistice Capital
New York
|
-$7.36M |
| 4 |
State Street
Boston,
Massachusetts
|
-$4.47M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4.41M |
